Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(52 sites)

United States

University of Colorado - Aurora Cancer Center, Aurora, Colorado

Mayo Clinic - Rochester, Rochester, Minnesota

Gabrail Cancer Center, Canton, Ohio

University of Cincinnati (UC) Physicians Company, LLC, Cincinnati, Ohio

Ohio State University, Columbus, Ohio

University of Texas, MD Anderson Cancer Center, Houston, Texas

Australia

Border Medical Oncology, East Albury

Southern Oncology Specialists, Kogarah

Royal Perth Hospital, Perth

St Vincent's Hospital Sydney, Sydney

Belgium

Chu De Liège, Liège

Cliniques Universitaires Saint-Luc, Woluwe-Saint-Lambert

Brazil

Instituto de Estudos e Pesquisas Sao Lucas - IEP - Sao Lucas, São Paulo

Bulgaria

University Hospital "St Ivan Rilski", Sofia

Military Medical Academy, Sofia

France

CH Le Mans, Le Mans

CHU de Nantes - Hôtel-Dieu, Nantes

CHU de Nice - Hopital L' Archet II, Nice

Germany

Universitaetsklinikum Carl Gustav Carus Dresden, Dresden

Marien Hospital Duesseldorf, Düsseldorf

Klinik fur Innere Medizin IV - Hamatologie/Onkologie, Universitatsklinikum Hall, Halle

Universitaetsklinikum Jena, Jena

Praxisklinik fur Hamatologie und Onkologie, Koblenz

Hungary

Debreceni Egyetem Klinikai Kozpont, Debrecen

Markhot Ferenc Oktatokorhaz es Rendelointezet, Eger

Szabolcs-Szatmár-Bereg Megyei Önkormányzat Jósa András Oktatókórház Megyei-Városi Tüdőgondozó Intézete, Nyíregyháza

Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz, Székesfehérvár

Italy

Azienda Ospedaliero Universitaria Policlinico G. Rodolico-San Marco - Presidio Ospedaliero G. Rodolico, Catania

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori, Meldola

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milan

ASST Grande Ospedale Metropolitano Niguarda, Milan

Azienda Ospedaliero Universitaria Maggiore Della Carita', Novara

Azienda Ospedaliera di Perugia-Ospedale S. Maria della Misericordia, Perugia

AUSL della Romagna-Ospedale S.Maria delle Croci, Ravenna

Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Reggio Calabria

Azienda Ospedaliero Universitaria Policlinico Umberto I, Roma

Poland

Szpital Uniwersytecki Nr 2 im. Dr Jana Biziela w Bydgoszczy, Klinika Hematologi, Bydgoszcz

Uniwersyteckie Centrum Kliniczne, Klinika Hematologii i Transplantologii, Gdansk

Klinika Hematologii Collegium Medicum Uniwersytetu Jagiellonskiego, Krakow

Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wroclawiu, Klinika Hematologii, Nowotworów Krwi i Transplantacji Szpiku, Wroclaw

South Korea

Kyungpook National University Hospital, Daegu

Seoul National University Hospital, Seoul

Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul

Spain

Institut Catala d'Oncologia - L'Hospitalet, Barcelona

Hospital Germans Trias i Pujol, Barcelona

Hospital Universitario 12 de Octubre, Madrid

Salamanca University Hospital, Salamanca

Hospital Quirónsalud Zaragoza, Zaragoza

Taiwan

Kaohsiung Medical University Chung-Ho Memorial Hospital (KMUH), Kaohsiung City

Chang Gung Memorial Hospital - Kaohsiung Branch, Kaohsiung City

China Medical University Hospital, Taichung

National Taiwan University Hospital, Taipei

Trial locations(52 sites)

Interested in joining?